“I think it will help you as a doctor to know you’re doing a treatment not only for 3 months, but that the treatment benefit is going to last for at least 2 years,” said Yvo Roos, MD. “It’s going to help you be more convincing to the relatives that you’re doing the right thing, that you’re doing something that’s really going to help them."
The above quote is in reference to new long-term followup data published as of April 6th, 2017, which now confirms and extends the outcomes of the MR CLEAN endovascular therapy trial in acute ischemic stroke patients. The results show that 1 out of every 3 patients treated with catheter based intervention are returning home to care for themselves within 3 months and these results are durable up to 2 years! Read the full details of the follow up data right here.
Team Pulsara: Jul 11, 2024
The mental health of America’s youth is under duress, and it didn’t start with COVID-19. It’s a problem that’s been a much longer time coming. In...
Kinsie Clarkson: Jul 02, 2024
Imagine: In the midst of a pandemic, you're managing patient load across a state that covers over 261,000 square miles and is home to over 30 million...
Kinsie Clarkson: Jun 19, 2024
Patient tracking during MCIs and pre-planned events is a complex operation with many moving parts. Every incident is different and requires different...
Brittney Nelson, BSN, RN, SCRN